<div id="readability-page-1"><div><p>As global markets navigate a complex landscape marked by cautious Federal Reserve commentary and mixed economic signals, investors are increasingly focused on identifying growth opportunities amidst the uncertainty. In such an environment, companies with high insider ownership often stand out as potentially resilient players, as this can indicate strong confidence from those closest to the business in its long-term prospects.</p><h3>Top 10 Growth Companies With High Insider Ownership Globally</h3><table><tbody><tr><td><strong>Name</strong></td><td><strong>Insider Ownership</strong></td><td><strong>Earnings Growth</strong></td></tr><tr><td>Seers Technology (KOSDAQ:A458870)</td><td>33.9%</td><td>84.6%</td></tr><tr><td>Pharma Mar (BME:PHM)</td><td>11.9%</td><td>44.2%</td></tr><tr><td>Laopu Gold (SEHK:6181)</td><td>35.5%</td><td>34%</td></tr><tr><td>KebNi (OM:KEBNI B)</td><td>38%</td><td>63.7%</td></tr><tr><td>J&amp;V Energy Technology (TWSE:6869)</td><td>17.5%</td><td>24.9%</td></tr><tr><td>Gold Circuit Electronics (TWSE:2368)</td><td>31.4%</td><td>35.2%</td></tr><tr><td>Fulin Precision (SZSE:300432)</td><td>11.8%</td><td>50.7%</td></tr><tr><td>Elliptic Laboratories (OB:ELABS)</td><td>24.4%</td><td>97.5%</td></tr><tr><td>CD Projekt (WSE:CDR)</td><td>29.7%</td><td>43.5%</td></tr><tr><td>Ascentage Pharma Group International (SEHK:6855)</td><td>12.8%</td><td>91.9%</td></tr></tbody></table><p>Click here to see the full list of 847 stocks from our Fast Growing Global Companies With High Insider Ownership screener.</p><p>Here we highlight a subset of our preferred stocks from the screener.</p><h2>Suzhou Zelgen Biopharmaceuticals (SHSE:688266)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Suzhou Zelgen Biopharmaceuticals Co., Ltd. is a biopharmaceutical company focused on the research, development, and commercialization of innovative drugs, with a market cap of approximately CN¥28.65 billion.</p><p><strong>Operations:</strong> The company generates revenue primarily from its pharmaceuticals segment, amounting to CN¥667.91 million.</p><p><strong>Insider Ownership:</strong> 29.4%</p><p><strong>Revenue Growth Forecast:</strong> 38% p.a.</p><p>Suzhou Zelgen Biopharmaceuticals exhibits significant growth potential, with revenue forecasted to increase by 38% annually, outpacing the broader Chinese market. Despite a net loss of CNY 72.8 million in H1 2025, revenue rose to CNY 375.65 million from CNY 240.7 million year-on-year. The stock trades at a substantial discount to its estimated fair value and is expected to achieve profitability within three years, though recent share price volatility remains a consideration for investors.</p><ul><li>Take a closer look at Suzhou Zelgen Biopharmaceuticals' potential here in our earnings growth report.</li><li>Our valuation report unveils the possibility Suzhou Zelgen Biopharmaceuticals' shares may be trading at a premium.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/887c3d2e-7c9f-4df4-849f-db1f7633a463/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/887c3d2e-7c9f-4df4-849f-db1f7633a463/chart/earnings-and-revenue-growth"/><figcaption>SHSE:688266 Earnings and Revenue Growth as at Sep 2025</figcaption></figure><h2>Beijing Relpow Technology (SZSE:300593)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Beijing Relpow Technology Co., Ltd manufactures and sells power supply products both in China and internationally, with a market cap of CN¥10.09 billion.</p><p><strong>Operations:</strong> Beijing Relpow Technology Co., Ltd generates revenue from the manufacturing and sale of power supply products within China and on a global scale.</p><p><strong>Insider Ownership:</strong> 28.8%</p><p><strong>Revenue Growth Forecast:</strong> 32.7% p.a.</p><p>Beijing Relpow Technology is poised for substantial growth, with revenue expected to rise by 32.7% annually, surpassing the broader Chinese market's growth rate. Despite reporting a net loss of CNY 95.14 million in H1 2025, the company shows promise with forecasts indicating profitability within three years. Recent amendments to its articles of association may signal strategic shifts, though investors should be mindful of its highly volatile share price and low projected return on equity.</p><ul><li>Navigate through the intricacies of Beijing Relpow Technology with our comprehensive analyst estimates report here.</li><li>Our comprehensive valuation report raises the possibility that Beijing Relpow Technology is priced higher than what may be justified by its financials.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1bc2d062-4035-4f19-815c-8d4dfef3e358/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1bc2d062-4035-4f19-815c-8d4dfef3e358/chart/ownership-breakdown"/><figcaption>SZSE:300593 Ownership Breakdown as at Sep 2025</figcaption></figure><h2>POCO Holding (SZSE:300811)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> POCO Holding Co., Ltd. specializes in the development, production, and sale of alloy soft magnetic powder and components for electronic equipment, with a market cap of CN¥21.71 billion.</p><p><strong>Operations:</strong> POCO Holding Co., Ltd. generates revenue primarily from the sale of alloy soft magnetic powder, alloy soft magnetic core, and related inductance components for electronic equipment.</p><p><strong>Insider Ownership:</strong> 24%</p><p><strong>Revenue Growth Forecast:</strong> 22.7% p.a.</p><p>POCO Holding demonstrates potential as a growth company, with revenue forecasted to grow at 22.7% annually, outpacing the Chinese market. Despite its volatile share price and low expected return on equity of 18.7%, earnings are projected to increase significantly at 26.11% per year. Recent amendments to the company's articles of association suggest strategic changes, though there is no substantial insider trading activity reported over the past three months.</p><ul><li>Dive into the specifics of POCO Holding here with our thorough growth forecast report.</li><li>Our expertly prepared valuation report POCO Holding implies its share price may be too high.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/earnings-and-revenue-growth"/><figcaption>SZSE:300811 Earnings and Revenue Growth as at Sep 2025</figcaption></figure><h2>Summing It All Up</h2><ul><li>Unlock our comprehensive list of 847 Fast Growing Global Companies With High Insider Ownership by clicking here.</li><li>Curious About Other Options? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.      It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.      All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p></div></div>

300811

688266

<p>As global markets face uncertainty, companies with high insider ownership are gaining attention for their growth potential. Notable firms include Suzhou Zelgen Biopharmaceuticals, expected to grow revenue by 38% annually, and Beijing Relpow Technology, with a forecast of 32.7% growth. POCO Holding anticipates a 22.7% revenue increase. Despite recent losses, these companies show promise for future profitability, although share price volatility remains a concern for investors.</p>

3 Global Growth Companies With High Insider Ownership Expecting 38% Revenue Growth